🇺🇸 FDA
Patent

US 6566358

Cyclocarbamate derivatives as progesterone receptor modulators

expired A61PA61P15/00A61P15/18

Quick answer

US patent 6566358 (Cyclocarbamate derivatives as progesterone receptor modulators) held by Ligand Pharmaceuticals Incorporated expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61P, A61P15/00, A61P15/18, A61P35/00, A61P43/00